lamotrigine/sertraline (LAM/SER) / Meditop Pharma 
Welcome,         Profile    Billing    Logout  
  Diseases    Trials    Trials    News 
  • ||||||||||  sertraline / Generic mfg.
    [VIRTUAL] Separation Anxiety Disorder in Children Mistaken for Autism Spectrum Disorder: Psychosocial Correlates and Clinical Evidence () -  May 2, 2021 - Abstract #APA2021APA_448;    
    In this poster, we highlight the overlap in symptomatology and differences between ASD and separation anxiety disorder and demonstrate the relevance of establishing a therapeutic alliance and interacting with patients to comprehend the underlying dynamics between patients and their main attachment figures [5]. We also emphasize the extrapolation of those dynamics to patients’ interactions with others to better understand their presenting problems and clarify the differential diagnosis, which is of crucial importance due to the effectiveness of early intervention.
  • ||||||||||  sertraline / Generic mfg.
    [VIRTUAL] Improvement of Superimposed Pseudo Seizures in a Patient With Anxiety Disorder () -  May 2, 2021 - Abstract #APA2021APA_322;    
    Patient was started on Lamotrigine, Sertraline and Clonazepam, with improvement of her symptoms. This case highlights the importance to be vigilant for pseudoseizures1 since misdiagnosis can often lead to inappropriate treatment, increase in readmission rates and comorbidities5.
  • ||||||||||  [VIRTUAL] Electroconvulsive therapy for agitation in Lewy Bodies Dementia (Station 04) -  Feb 20, 2020 - Abstract #EPA2020EPA_400;    
    Medication trials including donepezil, memantine, lamotrigine, sertraline, quetiapine, risperidone and melatonine, all failed to manage his depressive, psychotic and behavorial disturbances. This case suggests that ECT has an impact in the treatment of agitation in DLB patients, although further investigation is needed.
  • ||||||||||  sertraline / Generic Mfg.
    Clinical, Journal:  Hallucinogen persisting perception disorder: A literature review and three case reports. (Pubmed Central) -  Oct 17, 2019   
    The first case report describes a 23-year old patient with a previous history of cannabis consumption who reported HPDD type I after the use of psilocybin mushrooms with small amounts of alcohol and hash...Both patients sought medical help and received tofisopam, lamotrigine and sertraline...Scientific sources suggest that HPPD may affect more than 50% of hallucinogen users and this disorder is often underdiagnosed. Therefore, patients suffering from HPPD can present in various clinical settings, and clinicians should be aware of this condition.